126 related articles for article (PubMed ID: 28283087)
1. Bisdemethoxycurcumin enhances X-ray-induced apoptosis possibly through p53/Bcl-2 pathway.
Enomoto A; Yamada J; Morita A; Miyagawa K
Mutat Res Genet Toxicol Environ Mutagen; 2017 Mar; 815():1-5. PubMed ID: 28283087
[TBL] [Abstract][Full Text] [Related]
2. Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways.
Li YB; Gao JL; Zhong ZF; Hoi PM; Lee SM; Wang YT
Pharmacol Rep; 2013; 65(3):700-9. PubMed ID: 23950593
[TBL] [Abstract][Full Text] [Related]
3. Bisdemethoxycurcumin induces DNA damage and inhibits DNA repair associated protein expressions in NCI-H460 human lung cancer cells.
Yu CC; Yang ST; Huang WW; Peng SF; Huang AC; Tang NY; Liu HC; Yang MD; Lai KC; Chung JG
Environ Toxicol; 2016 Dec; 31(12):1859-1868. PubMed ID: 26332341
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways.
Mohankumar K; Pajaniradje S; Sridharan S; Singh VK; Ronsard L; Banerjea AC; Selvanesan BC; Coumar MS; Periyasamy L; Rajagopalan R
Cell Oncol (Dordr); 2014 Dec; 37(6):439-54. PubMed ID: 25433549
[TBL] [Abstract][Full Text] [Related]
5. Bisdemethoxycurcumin promotes apoptosis in human platelets via activation of ERK signaling pathway.
Paul M; Manikanta K; Hemshekhar M; Sundaram MS; Naveen S; Ramesh TN; Kemparaju K; Girish KS
Toxicol In Vitro; 2020 Mar; 63():104743. PubMed ID: 31809793
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic fabricated bisdemethoxycurcumin thermosensitive liposome with enhanced antitumor effect.
Cao X; Liu Q; Shi W; Liu K; Deng T; Weng X; Pan S; Yu Q; Deng W; Yu J; Wang Q; Xiao G; Xu X
Int J Pharm; 2023 Jun; 641():123039. PubMed ID: 37225026
[TBL] [Abstract][Full Text] [Related]
7. Bisdemethoxycurcumin-induced S phase arrest through the inhibition of cyclin A and E and induction of apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathways in human lung cancer NCI H460 cells.
Yang ST; Huang AC; Tang NY; Liu HC; Liao CL; Ji BC; Chou YC; Yang MD; Lu HF; Chung JG
Environ Toxicol; 2016 Dec; 31(12):1899-1908. PubMed ID: 26370218
[TBL] [Abstract][Full Text] [Related]
8. Autophagy Accompanied with Bisdemethoxycurcumin-induced Apoptosis in Non-small Cell Lung Cancer Cells.
Xu JH; Yang HP; Zhou XD; Wang HJ; Gong L; Tang CL
Biomed Environ Sci; 2015 Feb; 28(2):105-15. PubMed ID: 25716561
[TBL] [Abstract][Full Text] [Related]
9. Active Compounds from
Lesmana R; Susianti ; Pediatama T; Sylviana N; Susanti Pratiwi Y; Goenawan H; Supratman U
Pak J Biol Sci; 2021 Jan; 24(1):35-41. PubMed ID: 33683029
[TBL] [Abstract][Full Text] [Related]
10. Combinational treatment of all-trans retinoic acid (ATRA) and bisdemethoxycurcumin (BDMC)-induced apoptosis in liver cancer Hep3B cells.
Huang TY; Peng SF; Huang YP; Tsai CH; Tsai FJ; Huang CY; Tang CH; Yang JS; Hsu YM; Yin MC; Huang WW; Chung JG
J Food Biochem; 2020 Feb; 44(2):e13122. PubMed ID: 31837044
[TBL] [Abstract][Full Text] [Related]
11. Bisdemethoxycurcumin Induces apoptosis in activated hepatic stellate cells via cannabinoid receptor 2.
Lee PJ; Woo SJ; Jee JG; Sung SH; Kim HP
Molecules; 2015 Jan; 20(1):1277-92. PubMed ID: 25594342
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
13. Bisdemethoxycurcumin inhibits ovarian cancer via reducing oxidative stress mediated MMPs expressions.
Pei H; Yang Y; Cui L; Yang J; Li X; Yang Y; Duan H
Sci Rep; 2016 Jun; 6():28773. PubMed ID: 27349797
[TBL] [Abstract][Full Text] [Related]
14. Bisdemethoxycurcumin Induces Cell Apoptosis and Inhibits Human Brain Glioblastoma GBM 8401/
Hsia TC; Peng SF; Chueh FS; Lu KW; Yang JL; Huang AC; Hsu FT; Wu RS
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008959
[TBL] [Abstract][Full Text] [Related]
15. Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and -independent apoptosis via Smad or Akt signaling pathways in HOS cells.
Huang C; Lu HF; Chen YH; Chen JC; Chou WH; Huang HC
BMC Complement Med Ther; 2020 Mar; 20(1):68. PubMed ID: 32126993
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
17. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism.
Sandur SK; Pandey MK; Sung B; Ahn KS; Murakami A; Sethi G; Limtrakul P; Badmaev V; Aggarwal BB
Carcinogenesis; 2007 Aug; 28(8):1765-73. PubMed ID: 17522064
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between Noxa, Bcl-2, and ceramide in mediating p53-dependent apoptosis in Molt-4 human T-cell leukemia.
Kobeissy H; Hage-Sleiman R; Dakdouk Z; Kozhaya L; Dbaibo G
Mol Cell Biochem; 2020 Dec; 475(1-2):215-226. PubMed ID: 32767230
[TBL] [Abstract][Full Text] [Related]
19. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA.
Yodkeeree S; Chaiwangyen W; Garbisa S; Limtrakul P
J Nutr Biochem; 2009 Feb; 20(2):87-95. PubMed ID: 18495463
[TBL] [Abstract][Full Text] [Related]
20. Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory.
Jin F; Chen X; Yan H; Xu Z; Yang B; Luo P; He Q
Eur J Pharmacol; 2020 May; 874():173026. PubMed ID: 32088177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
